Hughes Steven George 4
4 · Avidity Biosciences, Inc. · Filed Oct 24, 2025
Insider Transaction Report
Form 4
Hughes Steven George
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-22$10.16/sh+2,209$22,443→ 41,076 total - Sale
Common Stock
2025-10-22$47.54/sh−2,209$105,015→ 38,867 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-22−2,209→ 68,458 totalExercise: $10.16Exp: 2034-01-19→ Common Stock (2,209 underlying)
Footnotes (3)
- [F1]The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.83 to $49.30. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option was granted on January 20, 2024 and vests in equal installments of 2,208 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on January 20, 2028.